Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Anti-HIV drugs].

F Raffi1

  • 1Maladies infectieuses et tropicales CHU, Nantes.

La Revue Du Praticien
|December 1, 1999
PubMed
Summary

This study reviews anti-HIV drugs that inhibit viral replication by targeting reverse transcriptase or protease enzymes. It categorizes reverse transcriptase inhibitors and discusses protease inhibitor efficacy and limitations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

False-negative result in fourth-generation HIV screening tests after weak detection of p24 antigen in the context of inappropriate post-exposure prophylaxis use: a case report.

The Journal of antimicrobial chemotherapy·2026
Same author

[Usage of non nucleosidic inhibitors of the HIV reverse transcriptase].

Virologie (Montrouge, France)·2021
Same author

Risk factors for HIV infection among men who have sex with men in the ANRS IPERGAY PrEP trial.

Sexually transmitted infections·2021
Same author

Dramatic decline in new HIV diagnoses in persons born in France in a large nationwide HIV cohort.

Public health·2021
Same author

Influence of HLA-C environment on the spontaneous clearance of hepatitis C in European HIV-HCV co-infected individuals.

Clinical and experimental immunology·2020
Same author

Ibrutinib, a Bruton's tyrosine kinase inhibitor, a new risk factor for cryptococcosis.

Medecine et maladies infectieuses·2020

Area of Science:

  • Pharmacology
  • Virology
  • Drug Development

Context:

  • Human Immunodeficiency Virus (HIV) replication is a complex intracellular process.
  • Targeting viral enzymes like reverse transcriptase and protease is a key strategy in anti-HIV drug development.

Purpose:

  • To summarize the mechanisms of action for anti-HIV drugs.
  • To categorize different classes of anti-HIV therapeutics.
  • To highlight the challenges and limitations associated with current anti-HIV treatments.

Summary:

  • Anti-HIV drugs function by inhibiting the intracellular replication of the virus.
  • Key targets include viral enzymes: reverse transcriptase and protease.
  • Reverse transcriptase inhibitors are categorized into nucleoside analogues, non-nucleoside inhibitors, and nucleotide analogues.
  • Protease inhibitors, while effective in vitro, present challenges including digestive side effects, significant drug interactions due to P450 metabolism, and long-term toxicity.

Impact:

  • Understanding these drug mechanisms is crucial for optimizing HIV treatment regimens.
  • Identifies the need for developing safer and more effective anti-HIV therapies with fewer side effects and drug interactions.

Related Experiment Videos